ethyl loflazepate has been researched along with Brain Diseases in 1 studies
ethyl loflazepate: structure given in first source
Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohira, T | 1 |
| Azuma, A | 1 |
| Matsuda, I | 1 |
1 trial available for ethyl loflazepate and Brain Diseases
| Article | Year |
|---|---|
[Effect of ethyl loflazepate on age-dependent epileptic encephalopathy].
Topics: Adolescent; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Brain Diseases; Child; Child, P | 1993 |